What we do
The ALA members work together to collect real-world data and tissue analyses which aim to identify key areas of unmet need for new clinical trial designs, and treatments for Lymphoma patients.
Patients
If you are a patient looking for further information, please visit our Patients page for list a useful websites.
Practice Statements
ALA members are working together to formulate a series of Consensus Practice Statements for diagnosis and management of key lymphoma subtypes.
View published statements here.
Partners
The ALA is supported by the Snowdome Foundation and works closely with a number of institutions and companies.
Projects
To read about projects completed by ALA members, please head to our Projects page. For access to ongoing projects, or to pitch a new project, please log in to our Members Only section
2024 Snowdome Annual Review
It’s now over seven years since the ALA was founded in 2018 by Professor Eliza Hawkes. Now under the leadership of Dr Pietro Di Ciaccio, who took over as Chair from Professor Chan Cheah in 2024, the ALA continues to grow, reaching 160 members across the Asia-Pacific region.
Read more about the achievements of the ALA in the 2024 Snowdome Annual Review, available here.
ALA Newsletter – Issue 25
Welcome to our May 2025 newsletter.
Click here to read the full newsletter.
ALA Newsletter – Issue 24
Welcome to our February 2025 newsletter.
Click here to read the full newsletter.